Cases & Deals

  • Home
  • Practices
  • Blue Point Capital sells controlling interest in TREK Diagnostic Systems

Share

Blue Point Capital sells controlling interest in TREK Diagnostic Systems

November 2006

Client(s) Blue Point Capital Partners

Jones Day advised Blue Point Capital Partners in connection with the sale of a controlling interest in TREK Diagnostic Systems, a global provider of products for microbiology labs, to Magellan Biosciences, Inc.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.